SCHEMBL1710031

SCHEMBL1710031

N/N=N\O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986767 1.00
SCHEMBL12744460 1.00
SCHEMBL571392 0.72
SCHEMBL15242143 0.71
SCHEMBL2017820 0.63
SCHEMBL2017821 0.63
SCHEMBL13555402 0.63
SCHEMBL278658 0.63
SCHEMBL1156928 0.63
SCHEMBL11246702 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190269629-A1 COMPOSITIONS AND METHODS FOR INHIBITING GROWTH OF ACSL4-OVEREXPRESSING TUMORS CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) (AR) 2019-09-05 US disclosed
WO-2018087641-A1 COMPOSITIONS AND METHODS FOR INHIBITING GROWTH OF ACSL4-OVEREXPRESSING TUMORS CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (CONICET) (AR) 2018-05-17 WO disclosed
EP-3228325-A1 PROTEIN-POLYMER-DRUG CONJUGATES Mersana Therapeutics, Inc. (US) 2017-10-11 EP disclosed
US-9409859-B2 Substituted diphenyl derivatives CREATIVE THERAPEUTICS GMBH (DE) 2016-08-09 US disclosed
EP-2689249-B1 ASSAY FOR SCREENING COMPOUNDS THAT SELECTIVELY DECREASE THE NUMBER OF CANCER STEM CELLS ROGOSIN INST (US) 2016-05-25 EP disclosed
US-20160021925-A1 FOOD PRINTING ADDITIVE LAYERING SUBSTRATE STRUCTURE INGESTIBLE MATERIAL PREPARATION SYSTEM AND METHOD ELWHA LLC 2016-01-28 US disclosed
US-20150050659-A1 PROTECTED FLUORESCENT REAGENT COMPOUNDS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2015-02-19 US disclosed
WO-2015021079-A1 PROTECTED FLUORESCENT REAGENT COMPOUNDS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2015-02-12 WO disclosed
US-8916046-B2 Method for controlling oxygen supply for treating wastewater, and facility for implementing same DEGREMONT (FR) 2014-12-23 US disclosed
WO-2014154957-A1 DYEING METHOD USING A HAIR-DYEING PRECURSOR OBTAINED FROM IRIDOIDS, COMPOSITION, PRECURSOR AND DEVICE INCLUDING SAME L'OREAL (FR) 2014-10-02 WO disclosed
US-6818313-B2 TO BE DEPOSITED ONTO STEEL OR CAST IRON SURFACES FOR ENHANCED CORROSION PROTECTION UNIVERSITY OF DAYTON 2004-11-16 US disclosed
WO-2004020616-A9 METHOD FOR DIAGNOSING VILLOUS TISSUE ATROPHY OF THE SMALL INTESTINE UNIV RUPRECHT KARLS HEIDELBERG (DE) 2004-06-17 WO disclosed
WO-2004020616-A1 METHOD FOR DIAGNOSING VILLOUS TISSUE ATROPHY OF THE SMALL INTESTINE Ruprecht-Karls-Universität Heidelberg (DE) 2004-03-11 WO disclosed
WO-2004009869-A2 CORROSION-INHIBITING COATING FOR METAL SURFACES UNIVERSITY OF DAYTON (US) 2004-01-29 WO disclosed
US-20040016363-A1 CORROSION-INHIBITING COATING VENTURE LENDING & LEASING, IV, INC. 2004-01-29 US disclosed
US-6645994-B1 Applying acetyl-CoA carboxylase inhibitors such as triacsin C, for prophylaxis of vision disorders ALCON, INC. (CH) 2003-11-11 US disclosed
EP-0015540-B1 NEW TRIAZENE COMPOUND, PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-06-22 EP disclosed
US-4297096-A HYPOTENSIVE AGENTS; MUSCLE RELAXANTS; STREPTOMYCES CULTURE FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 1981-10-27 US disclosed
EP-0015540-A2 New triazene compound, process for the preparation thereof, and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-09-17 EP disclosed
US-3989680-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1976-11-02 US disclosed